Novel Diagnostic Test for Pediatric Milk Allergy

DBV Technologies and Nestlé Health Science form collaboration to develop and commercialize a novel diagnostic test for pediatric milk allergy.
Collaboration will support DBV’s Mission to develop transformational product candidates for the care of pediatric patients suffering from food allergies
Under the terms of the agreement, DBV will develop a ready-to-use test to diagnose allergy to cow’s milk protein
DBV is eligible to receive up to €100 million in potential development, registration and commercial milestones, while granting global commercialization rights to Nestlé Heath Science.